As. Williams et al., DIFFERENTIAL-EFFECTS OF METHOTREXATE AND LIPOSOMALLY CONJUGATED METHOTREXATE IN RAT ADJUVANT-INDUCED ARTHRITIS, Clinical and experimental immunology, 102(3), 1995, pp. 560-565
In this study we evaluated the comparative efficacy of free and liposo
mally conjugated methotrexate on both disease induction and suppressio
n of acute inflammation in rat adjuvant-induced arthritis. Rats were g
iven either empty liposomes (E-LIPO), free methotrexate (MTX) or the l
iposomally conjugated methotrexate (MTX-LIPO) at a dose of 100 mu g/da
y for 7 consecutive days by the intravenous route. When MTX treatment
was initiated on the day of arthritis induction the drug suppressed bu
t did not abolish the development of joint inflammation. Free MTX had
no significant anti-inflammatory effect upon an established arthritis
when dosing was commenced on day 11 post-adjuvant induction. Conversel
y, MTX-LIPO did not affect the progression of the arthritis when dosin
g was started on day 0, but exerted a significant anti-inflammatory ef
fect on an established arthritis. MTX-LIPO treatment was significantly
less haematotoxic than free MTX.